I Upgraded FormFactor To Strong Buy, Now I'm Raising My Price Target

FormFactor reported Q2 2026 revenue of $258.2 million and non-GAAP EPS of $0.82, exceeding expectations, while guiding for another record Q3. The analyst maintained a Strong Buy rating and raised the price target 27% to $170 from $134, citing accelerating earnings growth. HBM demand remains a key driver, with newly qualified advanced MEMS technology expanding FORM's opportunity in GPU and custom ASIC testing.

Analysis

FORM’s incremental earnings power is increasingly tied to probe-card content and utilization rather than simply semiconductor unit growth. Qualification at a leading-edge foundry can create a high-switching-cost revenue stream: once a probe technology is embedded in yield-learning and volume test flows, displacement risk is low and gross-margin leverage can be meaningful. The likely competitive read-through is negative for Teradyne (TER) only at the margin—FORM is more exposed to wafer test interface than TER’s broader system-test franchise—but positive FORM execution could pressure smaller probe-card suppliers and reinforce its share gains in advanced-node test.

The key 1-3 month catalyst is whether management converts the current demand backdrop into a higher forward revenue floor rather than another single-quarter peak. Investors should focus on backlog duration, advanced-node mix, and whether custom ASIC demand broadens beyond a small number of hyperscaler programs; these determine whether the market can underwrite a multiple expansion rather than merely higher near-term EPS. A miss in foundry ramp timing, declining HBM test intensity, or a customer inventory correction would be disproportionately damaging because the stock’s valuation will increasingly capitalize a durable-AI-infrastructure thesis.

Consensus may still be modeling FORM principally as an HBM beneficiary, understating the strategic value of foundry-qualified MEMS capability across GPUs and custom ASICs. Conversely, the bullish case can become crowded quickly if quarterly upside is driven by expedited shipments or utilization rather than structural content gains. The thesis is falsified if the next guidance cycle shows advanced packaging/ASIC strength without corresponding gross-margin expansion or if management indicates qualification has not translated into production-volume orders.

Key Decisions for Investors

• Initiate or add to FORM on post-results consolidation rather than chase an opening-gap move; target a 6-12 month holding period, with upside dependent on a sustained advanced-node revenue mix and operating leverage. Size modestly until backlog duration and customer concentration are disclosed or independently corroborated.
• Use a long FORM / short TER pair for the next 1-3 months only if FORM’s relative performance has not already materially re-rated: FORM offers more direct upside to wafer-level AI test content, while TER provides partial semiconductor-test-cycle hedge. Exit if TER demonstrates offsetting system-test demand strength or FORM guides to flat sequential margins.
• For defined downside, buy FORM put spreads dated through the next earnings report against a core long position if implied volatility remains below the prior earnings-event range. The hedge is warranted because a production-ramp delay can compress both estimates and the AI-content multiple simultaneously.
• Set an earnings-call watch item: add only if management confirms production-volume orders at the foundry and provides evidence that custom ASIC revenue is diversified. Do not add on headline revenue strength alone if it is accompanied by weaker gross margin, elevated receivables, or inventory growth.